Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NVAX Novavax > Detailed Quotes

NVAX Novavax

18.570
-1.040-5.30%
Close 09/29 16:00 ET
18.500
-0.070-0.38%
Post Mkt Price 09/29 16:32 ET
High
19.410
Open
19.386
Turnover
78.02M
Low
17.850
Pre Close
19.610
Volume
4.22M
Market Cap
1.45B
P/E(TTM)
Loss
52wk High
236.500
Shares
78.22M
P/E(Static)
Loss
52wk Low
17.850
Float Cap
1.45B
Bid/Ask %
-33.33%
Historical High
331.680
Shs Float
77.91M
Volume Ratio
0.59
Historical Low
3.540
Dividend TTM
--
Div Yield TTM
--
P/B
-3.48
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
5.42%
Amplitude
7.96%
Avg Price
18.470
Lot Size
1
Float Cap
1.45B
Bid/Ask %
-33.33%
Historical High
331.680
Shs Float
77.91M
Volume Ratio
0.59
Historical Low
3.540
Dividend TTM
--
P/B
-3.48
Dividend LFY
--
Turnover Ratio
5.42%
Amplitude
7.96%
Avg Price
18.470
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
CEO: Mr. Stanley Charles Erck
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...